NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/02/2024
Voltar para busca
Dado oficial do USPTO
XCELLIT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
27/02/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10, 42, 44
Data de depósito
05/11/2022
Data de registro
27/02/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/02/2024
Última transação
27/02/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
03
Localização do titular
Mechelen, BE
Examinador
BERLIN, JUSTIN E
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized word "XCELLIT" with the right hand part of the "x" in green, the dot of the "i" in red, and the remainder of the letters in blue.
Titulares e representantes
Titulares
Galapagos NV
Representantes
Alexandra MacKay STITES & HARBISON PLLC
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
recorded software used as medical monitoring and control toolspecificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; recorded software as a medical device (SaMD)specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; recorded computer software for use in medical decision support systems specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment informationthat supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment
Classe 10
Medical apparatus and instruments for use in apheresisproduction of cell and gene therapiestestinganalysisquality assurance of cell and gene therapiesinfusion of cell and gene therapiesanalysis of data gathered from the cell and gene therapy treatment; apparatus and instruments for cell analysis for medical usecancer and autoimmune disease treatment; medical apparatus in the nature of a system comprising an automated manufacturing devicereagentssoftware for the purpose of coordinating the treatment of patientsmonitoring and conducting quality control on the testing of blood derived cellssupporting clinical decisions regarding the use of such cells for infusion and treatmentthe analysis of the results from such treatment
Classe 42
Software as a service (SAAS) services featuring software for medical monitoring and control specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowscheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; providing temporary use of nondownloadablecloud-based software featuring software for medical monitoring and control specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; software as a service (SAAS) services for use in medical decision support systemsspecificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment informationthat supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment; providing temporary use of non-downloadablecloud-based software featuring software for use in medical decision support systemsspecificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment informationthat supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment; Providing information about the results of clinical trials for pharmaceutical products; scientific research in the nature of conducting clinical trials; Providing information about the results of clinical trials; evaluation pharmaceutical products in the nature of product quality testing; providing information regarding the product quality testing and clinical trials of pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical product quality testing; advisory and consultancy services in the field of medical and pharmaceutical product development
Classe 44
Medical services; medical and pharmaceutical evaluation of medical and pharmaceutical products to determine effectiveness and suitability for use in treatment of specific medical conditions; medical servicescell therapy services; Medical services relating to the removaltreatment and processing of human cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
27/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2023
DOCK
ASSIGNED TO EXAMINER
06/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/08/2023
GNRT
NON-FINAL ACTION E-MAILED
24/08/2023
CNRT
NON-FINAL ACTION WRITTEN
24/08/2023
DOCK
ASSIGNED TO EXAMINER
21/08/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
19/01/2023
ALIE
ASSIGNED TO LIE
19/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/11/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
19/11/2022
NWAP
NEW APPLICATION ENTERED
09/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace XCELLIT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.